Tough comps, supply disruption and the ever-present pricing pressure impacts growth
SmartTRAK reports that the WW Trauma Market experienced a downturn in Q3, posting only +1.1% (reported) growth. The US Market was up +2.0% YoY, but is down sequentially compared to last quarter’s +5.0% gains...
Among the many topics covered in SmartTRAK's Q318 Trauma Market Recap are:
The Spine hardware market appears to be stabilizing.
SmartTRAK reports that results from a recent Leerink MEDACorp survey suggest that the US Spine market may be turning the corner, with hospital administrators reporting slightly improved case volume growth of 0.9% for Q318 vs 0.7% for Q2. This is consistent with Leerink’s intra-quarter checks and conversations at the North American Spine Society (NASS) 2018 Annual Meeting that the market...
Among the many topics covered in the Q318 Spine Market Recap are:
.png)
IRVINE, CA (PRWEB) JANUARY 02, 2019
Acquisitions and Partnerships are Highpoints in Q318
SmartTRAK reports that the US OrthoBio Market (comprised of Bone Replacement, Cartilage, Soft Tissue and Meniscus) is growing at 4.1% YTD. For Q318, there were no surprises and the segment reached...
Among the many topics covered in the Q318 OrthoBio Market Recap are:
SmartTRAK was excited to attend the 2018 Orthopaedic Summit (OSET), on December 5-8 at the Bellagio in Las Vegas, Nevada. And, our very own Kristina Meyer, Senior Analyst, Sports Medicine, landed on the front of the OSET banners. We always knew Kristina was a pretty big deal! Thanks OSET for the coverage.
Pricing pressure continues to dampen the US Joint Fluid market, which experienced a double-digit decline of -9.9% according to SmartTRAK's Financial Dashboard results. While the market continues to expand in terms of the number of patients treated, ASPs have steadily eroded over the past three quarters since the Anthem non-coverage decision kicked in earlier this year. Year-to-date, the US Joint Fluid market slowed significantly, posting negative growth according to SmartTRAK estimates...
It’s no surprise that Q318 US revenue growth accelerated YoY when, for the same period last year, the US Total Joints Market experienced major market disruption from two major hurricanes which delayed procedures beyond the usual Q3 procedural slowdown. Industry analysts, including Cantor Fitzgerald’s Craig Bijou, report that US recon growth was relatively flat on a stacked two-year basis. From this perspective, SmartTRAK believes this trend confirms the market is not showing major signs of improvement or decline...
Among the many topics covered in detail in the Q318 Total Joints Market Recap are:
SmartTRAK is so proud of its very latest cutting edge module, Computer-Assisted Surgery, both Spine and Ortho Segments. Elise Wolf, the creator of our Computer-Assisted Surgery Module, launched both in online webinars, the videos which are available to view now!
Elise Wolf, our Sr. Analyst for Computer Assisted Surgery, led both the webinars and has over 14 years of industry experience in roles including product development, marketing and business development consulting in robotics, emerging medical device technologies and orthopedics.
Please enjoy these overview videos of both modules.
Don't forget! BioMedGPS recently expanded coverage of SmartTRAK Business Intelligence in the realm of Robotic and Computer Assisted Surgery with the launch of the US Computer Assisted Surgery (CAS) – Ortho module on Tuesday, November 13th.
Please join Elise Wolf, Senior Analyst, Computer Assisted Surgery, for an introductory webinar on SmartTRAK’s newest product:The module provides real time, up-to-date market data, including 5-year market and procedural projections, quarterly revenue tracking, competitive overviews, clinical and regulatory activities and much more.
The new module covers:
The SmartTRAK Robotic and Computer Assisted Surgery module will be managed by Elise Wolf, a biomedical engineer that worked at a startup out of Carnegie Mellon University on robotic technologies early in her career. 
Robotics and other biological technologies created a buzz on the exhibit floor
Elise Wolf, Senior Analyst, Computer-Assisted Surgery, who manages the new Robotics and Computer-Assisted Surgery modules at SmartTRAK, reports on the new technologies in CAS that were being discussed at NASS 2018.
Robotics, navigation and other enabling technologies were hot topics at the North American Spine Society’s (NASS) 33rd annual meeting, held September 25-28, 2018 in Los Angeles, CA. Manufacturers are developing a variety of computer-assisted surgery (CAS) technologies for spine surgery, including surgical planning systems, navigation systems, robotics, augmented reality (AR) technology and artificial intelligence (AI). While growth in the fusion market has slowed over the past few years due to pricing pressure, reduced procedure volumes and reimbursement non-coverage, robotic and other CAS technologies have offered means for growth. With benefits that include more precise implant placement, reduced radiation exposure, decreased invasiveness of procedures and implant pull-through for manufacturers, CAS technologies are gaining traction.
Robotics
Robotics was a large topic of discussion during the meeting and on the exhibit floor. Spine market leader Medtronic (MDT) believes strongly in the future of robotics for spine surgery. At the Company’s recent investor conference, MDT executives estimated that up to 35% of instrumented spine procedures will be performed using robotics in 10 years. MDT believes its recent acquisition of Mazor (announced in September) will accelerate its product development and commercialization initiatives in robotics, and positions the Company to capture additional market share in both robotics revenues and core spine through implant pull-through. MDT management noted they are seeing high single-digit implant growth in accounts with capital equipment purchases of Mazor X, and double-digit growth in accounts that pay for the robotic system through multi-year, minimum volume commitments of incremental implant purchases. At NASS, MDT introduced the Mazor X Stealth, which integrates the Mazor robot with the Company’s StealthStation S8 navigation system. MDT submitted the 510(k) for Mazor X Stealth in July 2018 and the product launch is slated for year-end...
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.